heat News and Research

RSS

Reports: Climate change effects could increase hunger in developing countries by 2050

By 2050, climate change could lead to decreased outputs of corn, rice and wheat across the developing world resulting in price increases and hunger, according to an International Food Policy Research Institute (IFPRI) study, Bloomberg reports (Ruitenberg, 9/30).

1 Oct 2009

FEMA grant for designing next generation firefighter gloves

What is one of the biggest complaints firefighters have about their job? It's their gloves. While the current gloves are designed to provide protection against extreme temperatures, they are often bulky and inflexible. Through a recent Federal Emergency Management Agency (FEMA) grant, researchers at North Carolina State University will attempt to redesign the traditional firefighter glove to provide fire protection with less bulk and greater hand dexterity.

30 Sep 2009

Finance Senators picking sides as panel continues health bill markup

Politico: "Senate Finance Committee Chairman Max Baucus faces multiple challenges as he gavels in another week of work on health care Tuesday. High on the list: controlling the drama in the hearing room."

30 Sep 2009

San Francisco Medical Center acquires a BSD-500 Hyperthermia System

BSD Medical Corporation announced today that the University of California, San Francisco Medical Center (UCSF) has acquired a BSD-500 Hyperthermia System (BSD-500). UCSF is a world leader in hyperthermia and has the largest and most versatile hyperthermia program on the West Coast, and its world-renowned Radiation Oncology team has added the capabilities of the BSD-500 to its growing hyperthermia cancer treatment program.

29 Sep 2009

Synta commences Phase 1/2 clinical study of novel Hsp90 inhibitor in hematologic malignancies

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it has initiated a Phase 1/2 clinical study of its novel heat shock protein 90 (Hsp90) inhibitor, STA-9090 in hematologic malignancies with a once-a-week dosing schedule.

29 Sep 2009

New measles vaccination methods to reduce costs and improve safety

Worldwide, there are estimated to be 10 million cases of measles and 197,000 deaths from the disease each year. While vaccines exist to protect children against measles, the vaccines are often difficult to store, costly to transport and may be prone to contamination when shipped to developing countries.

29 Sep 2009

U.S. underfunds climate change health-related research

A recent commentary suggests that the U.S. should spend roughly $197 million more than it currently does to research the impact of climate change on public health.

28 Sep 2009

Restrictive policies in India discourages medical and pharmaceutical innovation: USIBC report

At a roundtable organized by the Coalition for Innovation Employment and Development, the U.S.-India Business Council's 'Coalition for Healthy India' released the findings of its report on "The Value of Incremental Pharmaceutical Innovation: Benefits for Indian Patients and Indian Business". The report highlights and substantiates the impact of restrictive policies in India, with respect to medical and pharmaceutical innovation.

24 Sep 2009

Hsp-27 protein helps identify aggressive prostate cancer

CANCER RESEARCH UK scientists have discovered a molecular 'flag' that predicts survival from prostate cancer at diagnosis, reveals a study published in the British Journal of Cancer.

24 Sep 2009

Golden nanotubes detect tumor cells, map sentinel lymph nodes

Biomedical researchers at the University of Arkansas in Fayetteville and the University of Arkansas for Medical Sciences (UAMS) in Little Rock have developed a special contrast-imaging agent made of gold-coated carbon nanotubes that is capable of molecular mapping of lymphatic endothelial cells and detecting cancer metastasis in sentinel lymph nodes.

23 Sep 2009

The ThermoDox and MR-HIFU program shows great promise for treating life-threatening cancers

Royal Philips Electronics (NYSE: PHG; AEX: PHI) and Celsion Corporation (NASDAQ: CLSN) today announced that their joint research program to evaluate ThermoDox® in combination with MR-HIFU (Magnetic Resonance guided High Intensity Focused Ultrasound) as a combination therapy to non-invasively treat difficult cancers has successfully completed the feasibility stage.

23 Sep 2009

Dust Alert sensor to monitor quality of air

Worried that dust from a nearby construction zone will harm your family's health? A new Tel Aviv University tool could either confirm your suspicions or better yet, set your mind at rest.

23 Sep 2009

Research reveals balancing act between sugar-coated nanoparticles

A research team at the National Institute of Standards and Technology (NIST) studying sugar-coated nanoparticles for use as a possible cancer therapy has uncovered a delicate balancing act that makes the particles more effective than conventional thinking says they should be. Just like individuals in a crowd respecting other people's personal space, the particles work because they get close together, but not too close.

23 Sep 2009

Hyperthermia with chemotherapy prolongs survival

BSD Medical Corporation (NASDAQ:BSDM) reports that significant and “medical practice changing” clinical study results were the subject of a news briefing at Europe’s largest cancer congress, ECCO15 – ESMO34, which is being held September 20 to 24, 2009, in Berlin, Germany.

23 Sep 2009

CDP commends Pfizer for addressing climate change practices

Pfizer Inc has been commended by the Carbon Disclosure Project (CDP) for its approach to addressing climate change. CDP named Pfizer to its Climate Disclosure Leadership Index, which highlights the company’s climate change disclosure practices. This is the third consecutive year that Pfizer has been recognized by CDP.

22 Sep 2009

Study reveals effectiveness of targeted heat therapy in addition to chemotherapy

Patients with soft-tissue sarcomas at high risk of spreading were 30% more likely to be alive and cancer free almost three years after starting treatment if their tumours were heated at the time they received chemotherapy, according to new research. The finding bolsters the case for intensifying exploration of the strategy in other types of cancer.

22 Sep 2009

Small business operators worried over proposed health care legislation

The U.S. Congress is back in session with Health Care legislation dominating the attention of lawmakers and the public. The current proposed health care legislation will mandate small business with payrolls more than $250,000 to provide health insurance to their workers or pay a fine.

22 Sep 2009

Biochemists are developing a new system to better understand antibiotic resistance

Rice University biochemists are developing a system of "evolutionary forecasting" to better understand the mechanisms of antibiotic resistance.

22 Sep 2009

Celsion recommended to continue patient enrollment in its ThermoDox Phase III liver cancer trial

Celsion Corporation (NASDAQ:CLSN) announced today the Data Safety Monitoring Board (“DSMB”) has reviewed the safety data from the first group of patients enrolled in its pivotal ThermoDox® Phase III clinical trial for primary liver cancer (“HEAT study”) and has recommended that Celsion continue to enroll patients in the trial.

21 Sep 2009

NIAID awards DOR BioPharma a $9M grant to develop thermostable and rapidly acting vaccines

DOR BioPharma, Inc. (OTC Bulletin Board: DORB) (DOR or the Company), a late-stage biotechnology company, announced today that it has been awarded an approximate $9.4 Million grant from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH).

21 Sep 2009

heat News and Research

Reports: Climate change effects could increase hunger in developing countries by 2050

FEMA grant for designing next generation firefighter gloves

Finance Senators picking sides as panel continues health bill markup

San Francisco Medical Center acquires a BSD-500 Hyperthermia System

Synta commences Phase 1/2 clinical study of novel Hsp90 inhibitor in hematologic malignancies

New measles vaccination methods to reduce costs and improve safety

U.S. underfunds climate change health-related research

Restrictive policies in India discourages medical and pharmaceutical innovation: USIBC report

Hsp-27 protein helps identify aggressive prostate cancer

Golden nanotubes detect tumor cells, map sentinel lymph nodes

The ThermoDox and MR-HIFU program shows great promise for treating life-threatening cancers

Dust Alert sensor to monitor quality of air

Research reveals balancing act between sugar-coated nanoparticles

Hyperthermia with chemotherapy prolongs survival

CDP commends Pfizer for addressing climate change practices

Study reveals effectiveness of targeted heat therapy in addition to chemotherapy

Small business operators worried over proposed health care legislation

Biochemists are developing a new system to better understand antibiotic resistance

Celsion recommended to continue patient enrollment in its ThermoDox Phase III liver cancer trial

NIAID awards DOR BioPharma a $9M grant to develop thermostable and rapidly acting vaccines

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News